Mayet Mayet
Product Blog Resources About
Contact Us
  1. Blog
  2. Author: Tom Lazenby
  3. Page 3
  • Vendor Horror Stories – Conference Recap

    Apr 24, 2024

    —

    by

    Tom Lazenby
    in General
    Vendor Horror Stories – Conference Recap

    Welcome back to the Mayet blog! As proud sponsors of this year’s Institute of Clinical Research Ethics and GCP Forum, we had the unique opportunity to engage directly incredible community at the forefront of clinical trials. A special thanks to the Institute for hosting us, to UCL for providing a fantastic venue, and to the…

    Read more »: Vendor Horror Stories – Conference Recap
  • Vendor Qualification: The Key to Ensuring Clinical Trial Success

    Apr 17, 2024

    —

    by

    Tom Lazenby
    in General
    Vendor Qualification: The Key to Ensuring Clinical Trial Success

    The success of a clinical trial significantly depends on the careful selection and management of external vendors. Vendor qualification is critical to an outsourcing strategy, ensuring that every entity involved in a trial meets the standards required for a successful outcome. This blog post explores the role of vendor qualification in clinical trials, including its…

    Read more »: Vendor Qualification: The Key to Ensuring Clinical Trial Success
  • Crafting Compliance in Trial Contracts

    Apr 10, 2024

    —

    by

    Tom Lazenby
    in General
    Crafting Compliance in Trial Contracts

    My perspective and ideas below are informed by my analysis of the EMA GCP Inspection Working Group Report 2022, which underscores the critical role of well-defined contractual agreements in the overarching framework of clinical trial management. The life cycle of a clinical trial is defined by the Protocol and what is required to be delivered,…

    Read more »: Crafting Compliance in Trial Contracts
  • Best Practices: Clinical Trial Vendor Selection and Qualification

    Apr 3, 2024

    —

    by

    Tom Lazenby
    in General
    Best Practices: Clinical Trial Vendor Selection and Qualification

    Choosing the right vendor is crucial for the success of clinical trials. This blog post serves as a practical guide for Clinical QA professionals, Outsourcing Leads, and Operating Managers embarking on the vendor assessment journey. I’ll cover the complex process of evaluating vendors, covering key areas such as their capabilities, delivery track record, compliance with…

    Read more »: Best Practices: Clinical Trial Vendor Selection and Qualification
  • Vendor Onboarding: Best Practices for Digital Integration

    Mar 13, 2024

    —

    by

    Tom Lazenby
    in General
    Vendor Onboarding: Best Practices for Digital Integration

    The integration of digital solutions is critical for organisation success and efficiency, particularly with the growing number and variety of systems available. The prospect of onboarding new vendors and ensuring seamless, robust and compliant software integrations can often seem daunting to pharmaceutical companies. The fear of non-compliance with Good Clinical Practice (GxP) regulations, coupled with…

    Read more »: Vendor Onboarding: Best Practices for Digital Integration
  • Critical to Quality Factors and Vendor Oversight

    Mar 6, 2024

    —

    by

    Tom Lazenby
    in General
    Critical to Quality Factors and Vendor Oversight

    A Systematic Redirection Towards Proactive Management Integrating risk-based quality management, and identifying and managing critical to quality factors has become a core activity of successful trial delivery. If you’re part of a clinical trial team or a clinical trial Sponsor organisation, you’re likely aware of the challenges and problems that accompany the requirements of vendor…

    Read more »: Critical to Quality Factors and Vendor Oversight
  • Enhancing Clinical Trial Partnerships through Effective Financial Analysis

    Feb 14, 2024

    —

    by

    Tom Lazenby
    in General
    Enhancing Clinical Trial Partnerships through Effective Financial Analysis

    Marked by increasing intricacies and soaring costs, clinical trials are always changing. In this landscape, the selection and management of vendor services stand out as a key element in enhancing operational efficiency and controlling expenditures. This blog post is intended to unpack the financial implications of vendor contributions in clinical trials, highlighting the potential of…

    Read more »: Enhancing Clinical Trial Partnerships through Effective Financial Analysis
  • A Practical Guide: Strategic Digital Integration in Clinical Operations

    Feb 7, 2024

    —

    by

    Tom Lazenby
    in General
    A Practical Guide: Strategic Digital Integration in Clinical Operations

    The evolution of clinical trials, characterised by increasingly complex trial designs and regulatory frameworks, requires a strategic approach to digital integration. As digital tools become more prevalent it is important for organisations to adopt technologies thoughtfully to enhance efficiency and remain competitive. Maximising Value through Strategic Investments A critical first step in digital integration is…

    Read more »: A Practical Guide: Strategic Digital Integration in Clinical Operations
  • RBQM: Surgical Precision in Vendor Management

    Jan 31, 2024

    —

    by

    Tom Lazenby
    in General
    RBQM: Surgical Precision in Vendor Management

    A Surgical Approach to Efficiency and Compliance The objective when delivering a clinical trial is to not only reach the goal but to complete with surgical precision. Risk-Based Quality Management (RBQM) is an instrumental framework, often not considered in the processes of clinical trial vendor management. Adopting RBQM enables a broad-stroke strategy to a tailored…

    Read more »: RBQM: Surgical Precision in Vendor Management
  • Mayet is proud to welcome a new Advisor and team member into the fold

    Jan 15, 2024

    —

    by

    Tom Lazenby
    in General
    Mayet is proud to welcome a new Advisor and team member into the fold

    Chris Shepherd on joining Mayet as an Advisor: “I am very excited to have been approached by Mayet to join as an advisor. Mayet has recognised a market need for an integrated software tool tailored to the biopharma industry. This tool will consolidate quality and performance KPIs, audits, risks, and various issues from multiple therapy…

    Read more »: Mayet is proud to welcome a new Advisor and team member into the fold
←Previous Page Next Page→

Search

Topics

  • General

Latest Posts

  • Mayet Goes Modular!
  • Integration Partnership with PHARMASEAL CTMS
  • Mayet Strengthens Quality Leadership with Addition of New Strategic Advisor
  • 8 Transformative ICH E6(R3) Service Provider Management Requirements
  • The Human Side of Clinical Trial Quality
  • Mayet Strengthens Commercial Leadership with Addition New Strategic Advisor
  • Vendor Risk Management: A Modern Approach

Footer

Mayet

Mayet Solutions Ltd
London, W1W 5PF
United Kingdom

Phone: +44 792 012 2927

LinkedIn

Mayet Software

  • Product
  • Request Demo

Resources

  • Briefing
  • Webinar
  • GCP R3 Seminar
  • White Paper
  • Resources

Company

  • Blog
  • Contact
  • About
  • Security & Compliance
  • Legal

© 2023-2024 Mayet Solutions Ltd – All rights reserved

Cyber Essentials Insurance Cyber Essentials Plus Certified